SXTP logo

SXTP Cash From Operations

Annual CFO

-$4.54 M
-$3.53 M-349.79%

December 1, 2023


Summary


Performance

SXTP Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSXTPcash flowmetrics:

Quarterly CFO

-$1.68 M
-$493.00 K-41.49%

September 1, 2024


Summary


Performance

SXTP Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSXTPcash flowmetrics:

TTM CFO

-$4.07 M
+$2.07 M+33.71%

September 1, 2024


Summary


Performance

SXTP TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSXTPcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SXTP Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-349.8%-47.4%+22.7%
3 y3 years-2615.4%-47.4%+22.7%
5 y5 years-2615.4%-47.4%+22.7%

SXTP Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-599.9%at low-2539.3%+55.2%-3870.3%+33.7%
5 y5-year-2615.4%at low-2539.3%+55.2%-3870.3%+33.7%
alltimeall time-2615.4%at low-2539.3%+55.2%-3870.3%+33.7%

60 Degrees Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.68 M(+41.5%)
-$4.07 M(-33.7%)
Jun 2024
-
-$1.19 M(+4.2%)
-$6.15 M(+16.6%)
Mar 2024
-
-$1.14 M(+1690.3%)
-$5.27 M(+16.0%)
Dec 2023
-$4.54 M
-$63.70 K(-98.3%)
-$4.54 M(-0.1%)
Sep 2023
-
-$3.75 M(+1097.2%)
-$4.55 M(+313.5%)
Jun 2023
-
-$313.50 K(-24.0%)
-$1.10 M(-16.7%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$412.70 K(+525.3%)
-$1.32 M(+30.7%)
Dec 2022
-$1.01 M(+55.6%)
-$66.00 K(-78.5%)
-$1.01 M(+7.0%)
Sep 2022
-
-$307.10 K(-42.5%)
-$944.10 K(+48.2%)
Jun 2022
-
-$534.40 K(+420.9%)
-$637.00 K(+520.9%)
Mar 2022
-
-$102.60 K
-$102.60 K
Dec 2021
-$649.10 K(+288.0%)
-
-
Dec 2020
-$167.30 K
-
-

FAQ

  • What is 60 Degrees Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for 60 Degrees Pharmaceuticals?
  • What is 60 Degrees Pharmaceuticals annual CFO year-on-year change?
  • What is 60 Degrees Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for 60 Degrees Pharmaceuticals?
  • What is 60 Degrees Pharmaceuticals quarterly CFO year-on-year change?
  • What is 60 Degrees Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for 60 Degrees Pharmaceuticals?
  • What is 60 Degrees Pharmaceuticals TTM CFO year-on-year change?

What is 60 Degrees Pharmaceuticals annual cash flow from operations?

The current annual CFO of SXTP is -$4.54 M

What is the all time high annual CFO for 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals all-time high annual cash flow from operations is -$167.30 K

What is 60 Degrees Pharmaceuticals annual CFO year-on-year change?

Over the past year, SXTP annual cash flow from operations has changed by -$3.53 M (-349.79%)

What is 60 Degrees Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of SXTP is -$1.68 M

What is the all time high quarterly CFO for 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals all-time high quarterly cash flow from operations is -$63.70 K

What is 60 Degrees Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, SXTP quarterly cash flow from operations has changed by -$540.80 K (-47.42%)

What is 60 Degrees Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of SXTP is -$4.07 M

What is the all time high TTM CFO for 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals all-time high TTM cash flow from operations is -$102.60 K

What is 60 Degrees Pharmaceuticals TTM CFO year-on-year change?

Over the past year, SXTP TTM cash flow from operations has changed by +$1.20 M (+22.71%)